Hair Loss Drugs

Most Clinics offer a range of ‘additives’ to the basic Minoxidil therapy. Progesterone and Tretinoin in the main. Or a combination of both. Progesterone, (an anti-androgen, purported to block the formation of the male hormone (testosterone) in the scalp). Allowing the Minoxidil to have more effect. Tretinoin – a derivative of Vitamin A is used as a ‘vehicle’, allowing the Minoxidil to penetrate the scalp more effectively. These are topical solutions applied to the scalp. Consequently, they remain ‘localised’ in the target area, rather than being absorbed into the main bloodstream. Unlike Finasteride, which is taken orally.

To those unfamiliar with Finasteride, let me explain a little of its history: Finasteride is a drug, which began life as a treatment for prostate cancer. As is occasionally the case with newly developed drugs, Finasteride was found to have a beneficial ‘side-effect’, totally unrelated to the drugs intended use. During the drugs initial clinical trials for prostate, it was realised that a considerable number of men being tested showed initial signs of growing some of their hair back. I read about this development in 1992 and commenced using the treatment myself shortly after that.

In 1997 (6 years after the manufacturers initial discover), The FDA (America’s Food & Drug Administration) licensed the drug for use as a hair growth treatment in the US. One could ask why, knowing Finasteride’s potential for growing hair, the manufacturers limited their clinical trials to only 12 months? Could it be that, had they extended the trials, they would have had to admit that their drug too, has limitations? Interestingly, a recent television report featured one man having complete re-grown his hair with the pill and one other looking like he was about to do the same. All I can say, is that after 11 years personal use of the pill and feedback from the hundreds of men who acquire treatments through my company’s Doctor – No one has re-grown significant volumes of new growth.

Yes, it can prevent further hair loss and does so for something like 84% (published) of users. Yes, it can improve the ‘volume’ and lustre of their existing hair. It can also produce the first signs of new growth but this growth tends to remain fine in texture and short in length. In amongst a man’s existing hair, the fine, short growth which achieves its original pigmentation, rather than remaining velus (translucent) gives a much-improved appearance to the overall ‘look’ of his hair. Unfortunately, to apply similar results to a bald scalp would appear insignificant.

Therefore, the way one views Finasteride’s success depends greatly on one’s current state of hair loss. To men who are just recognising the first, subtle signs of oncoming hair loss, Finasteride is all that’s required to ensure them of a hirsute future. That is, for as long as they continue its use. Stop taking the pill after a few years and all the hair the man has prevented from falling out – will disappear. Not over a period of years, as would likely have been the case but over a period of weeks. Hirsute to hair-less, in a few short weeks!

There are those, of course, who are simply happy to maintain the ‘status quo’. They can live with their hair loss as it stands but are unhappy at the thought of it getting any worse. These men too would value the treatment, especially if it improved on the overall appearance of their existing hair.

Finally, there are those who have lost some, but not all of their hair. They opt for hair-growth treatments, hoping that they are among the rare cases of ‘total re-call’ we occasionally see on television documentaries. Then, having likely narrowed the gap between what they had and what they wanted, they, as I have, opt for Hair Restoration Surgery to achieve their goal. Knowing that they do not face losing more hair, once the surgery is completed.

Contra Indications Propecia (finasteride)

In clinical trials, finasteride was very well tolerated in men, with most patients reporting no serious side effects. The principal side effects associated with finasteride were decreased libido (1.8% of finasteride patients versus 1.3% on placebo) and erectile dysfunction (1.3% finasteride versus 0.7% placebo). In addition, decreased volume of ejaculate was reported in 0.8% of men treated with finasteride and 0.4% of those on placebo. All of these side effects resolved upon discontinuation of therapy, and also resolved in many men who preferred to continue therapy.

Finasteride was evaluated in 3,200 men and it was very well tolerated, including patients on therapy for up to two years. Long-term suppression of DHT does not appear to be harmful. This is based on extensive research, dating back to 1974, of me
n born with a deficiency of 5-alpha reductase.

Finasteride is not indicated for use in women or children. Finasteride is contraindicated in women who are or may potentially be pregnant. Finasteride is contraindicated in patients who are hypersensitive to any component of the product.

No drug interactions of clinical importance have been identified. Studies have been conducted with finasteride and antipyrine, digoxin, glyburide, propranolol, theophylline, and warfarin, and no interactions were found. In clinical trials, finasteride was used concomitantly with ACE inhibitors, acetaminophen, alpha blockers, benzodiazepines, beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA Reductase inhibitors, prostaglandin synthesase inhibitors (NSAIDs), and quinolones, without evidence of clinically significant adverse interactions.

There are no human data supporting the use of this combination. Scientific studies would be required to assess the safety and efficacy of such a combination. At this time, no combination studies are planned.

Should you require any help or information on treatments,
please call us on: 08457 660087